CEO Healthcare Economics LLC
Healthcare Economics LLC
Dr. James Harris III has extensive experience in biotech, pharmaceuticals and medical devices with small start-ups, mid-sized and large firms. Mr. Harris is the founder of Healthcare Economics LLC, Co-founder of AS Biotech AG and participates on the board of directors as well as advisory boards for various firms. Prior to this he served as General Manager and Vice President at Dragon Pharmaceuticals, Inc. where he was instrumental in the launch and successful market penetration of rh-Erythropoietin (â€œEPO") in non patented markets and is very well experienced in product licensing, business development, market access and reimbursement. Mr. Harrisâ€™s publications include â€œBiosimilars landscape and FDA regulatory expectationsâ€, â€œGeneric Drugs: World Market Outlook 2011-2021â€, â€œPatient Empowerment and Compliance: The Role of Direct to Consumer (DTC) Advertisingâ€, â€œMarketing and Globalizing Biosimilarsâ€, â€œHow to Establish Comparability for a faster route to Market, and â€œGCSF and Bioequivalence: The Emergence of Healthcare Economicsâ€. Mr. Harris is Lead Faculty Area Chair â€“ Financial Planning and Risk Control at the University of Phoenix West Florida Campus, has an MBA in Finance from Long Island University and participates extensively as a featured speaker at medical meetings globally.
Biosimilars, Generic Drugs, IPR